Moonlake Immunotherapeutics · NASDAQ:MLTX

Reich Kristian sold 150,000 Moonlake Immunotherapeutics shares (Form 4)

Traded Jun 15 to Jun 17, 2026 · Filed Jun 17, 2026

From Jun 15 to Jun 17, 2026, Reich Kristian (Chief Scientific Officer) sold 150,000 Moonlake Immunotherapeutics shares at an average US$19.01 for US$2.85M under a trading plan, leaving 2,824,551 shares. Filed Jun 17, 2026 (Form 4).

Sold
150,000 shares
Price
US$19.01 average (US$18.70 to US$19.43)
Value
US$2.85M
Holding after
2,824,551 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Class A ordinary shares, par value $0.0001 per shareSale50,000US$18.892,924,551Indirect
Jun 16, 2026Class A ordinary shares, par value $0.0001 per shareSale50,000US$18.702,874,551Indirect
Jun 17, 2026Class A ordinary shares, par value $0.0001 per shareSale50,000US$19.432,824,551Indirect

Source

View original at SEC

Related